These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
882 related articles for article (PubMed ID: 15377287)
21. [Risk factors for hepatitis C among injecting drug users in Oslo]. Dalgard O; Egeland A; Ervik R; Vilimas K; Skaug K; Steen TW Tidsskr Nor Laegeforen; 2009 Jan; 129(2):101-4. PubMed ID: 19151801 [TBL] [Abstract][Full Text] [Related]
22. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus. Demetriou VL; van de Vijver DA; Hezka J; Kostrikis LG; ; Kostrikis LG J Med Virol; 2010 Feb; 82(2):263-70. PubMed ID: 20029809 [TBL] [Abstract][Full Text] [Related]
23. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh. Shirin T; Ahmed T; Iqbal A; Islam M; Islam MN J Health Popul Nutr; 2000 Dec; 18(3):145-50. PubMed ID: 11262767 [TBL] [Abstract][Full Text] [Related]
24. Hepatitis C prevalence and needle/syringe sharing behaviours in recent onset injecting drug users. Robinson GM; Reynolds JN; Robinson BJ N Z Med J; 1995 Mar; 108(996):103-5. PubMed ID: 7715873 [TBL] [Abstract][Full Text] [Related]
25. Factors associated with exposure to hepatitis B virus in injection drug users. Backmund M; Meyer K; Schuetz C; Reimer J Drug Alcohol Depend; 2006 Sep; 84(2):154-9. PubMed ID: 16481128 [TBL] [Abstract][Full Text] [Related]
26. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients. Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434 [TBL] [Abstract][Full Text] [Related]
27. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices. Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Carballo E; Barrio E Hepatogastroenterology; 2003; 50(54):2093-7. PubMed ID: 14696471 [TBL] [Abstract][Full Text] [Related]
28. Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users. Vassilev ZP; Hagan H; Lyubenova A; Tomov N; Vasilev G; Krasteva D; Des Jarlais DC Int J STD AIDS; 2006 Sep; 17(9):621-6. PubMed ID: 16942654 [TBL] [Abstract][Full Text] [Related]
29. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy. Guadagnino V; Zimatore G; Izzi A; Caroleo B; Rocca A; Montesano F; Costa C; Masciari R; Naso E; Biselli R J Clin Lab Immunol; 1995; 47(1):1-9. PubMed ID: 8735431 [TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus among injecting drug users in Sydney, Australia: prevalence, vaccination and knowledge of status. Day CA; White B; Dore GJ; van Beek I; Rodgers C; Cunningham P; Wodak A; Maher L Drug Alcohol Depend; 2010 Apr; 108(1-2):134-7. PubMed ID: 20047803 [TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004. Falster K; Kaldor JM; Maher L; J Urban Health; 2009 Jan; 86(1):106-18. PubMed ID: 18979201 [TBL] [Abstract][Full Text] [Related]
32. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy. Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712 [TBL] [Abstract][Full Text] [Related]
33. Risk Factors and predictors of human immunodeficiency virus infection among injection drug users. Backmund M; Meyer K; Henkel C; Reimer J; Wächtler M; Schütz CG Eur Addict Res; 2005; 11(3):138-44. PubMed ID: 15990431 [TBL] [Abstract][Full Text] [Related]
34. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran. Imani R; Karimi A; Rouzbahani R; Rouzbahani A East Mediterr Health J; 2008; 14(5):1136-41. PubMed ID: 19161086 [TBL] [Abstract][Full Text] [Related]
35. Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran. Zamani S; Radfar R; Nematollahi P; Fadaie R; Meshkati M; Mortazavi S; Sedaghat A; Ono-Kihara M; Kihara M Int J Drug Policy; 2010 Nov; 21(6):493-500. PubMed ID: 20483578 [TBL] [Abstract][Full Text] [Related]
36. Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty. Rhodes T; Davis M; Judd A Addiction; 2004 May; 99(5):621-33. PubMed ID: 15078237 [TBL] [Abstract][Full Text] [Related]
37. [Prevalence of human immunodeficiency virus and hepatitis C virus, and associated factors among injecting drug users in Catalonia]. Huntington S; Folch C; González V; Meroño M; Ncube F; Casabona J Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):236-8. PubMed ID: 19695744 [TBL] [Abstract][Full Text] [Related]
38. [Prevalence of hepatitis B, hepatitis C and HIV among injecting drug users treated outpatiently and in therapeutic community in Brod-Posavina County, Croatia]. Kolovrat A; Jurisić I; Marić Z; Cvitković A Acta Med Croatica; 2010 Oct; 64(4):287-96. PubMed ID: 21688612 [TBL] [Abstract][Full Text] [Related]
39. Tattooing in prisons--not such a pretty picture. Hellard ME; Aitken CK; Hocking JS Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561 [TBL] [Abstract][Full Text] [Related]
40. Distributive syringe sharing among young adult injection drug users in five U.S. cities. Golub ET; Strathdee SA; Bailey SL; Hagan H; Latka MH; Hudson SM; Garfein RS; Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S30-8. PubMed ID: 17398039 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]